Taken together, our data support hepatocyte PPARα as being essential to the prevention of NAFLD and that extra-hepatocyte PPARα activity contributes to whole-body lipid homeostasis. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.